What is Cardio Diagnostics Holdings Inc?
develops and commercializes epigenetics-based clinical tests for cardiovascular disease.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 4.74M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.